4.6 Review

Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies

Journal

FRONTIERS IN ONCOLOGY
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2019.00234

Keywords

FOXN3; forkhead; function; breast; cancer; malignancy; regulation; review

Categories

Funding

  1. Natural Science Foundation of China [81872160]
  2. Beijing Municipal Natural Science Foundation [7191009]
  3. Capital Public Health Education, Beijing Science and Technology Program [Z171100000417028]
  4. Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2017-I2M-3-020]

Ask authors/readers for more resources

FOXN3 (forkhead box N3; CHES1: check point suppressor 1) belongs to the forkhead box (FOX) protein family. FOXN3 displays transcriptional inhibitory activity, and is involved in cell cycle regulation and tumorigenesis. FOXN3 is a tumor suppresser and alterations in FOXN3 are found in of a variety of cancers including melanoma, osteosarcoma, and hepatocellular carcinoma. While the roles of FOXN3 role in some cancers have been explored, its role in breast cancer remains unclear. Here we describe current state of knowledge of FOXN3 functions, and focus on its roles (known and potential) in breast cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Expression signatures and roles of microRNAs in inflammatory breast cancer

Yihang Qi, Xiangyu Wang, Xiangyi Kong, Jie Zhai, Yi Fang, Xiaoxiang Guan, Jing Wang

CANCER CELL INTERNATIONAL (2019)

Review Oncology

Immunological therapy: A novel thriving area for triple-negative breast cancer treatment

Xiangyu Wang, Yihang Qi, Xiangyi Kong, Jie Zhai, Yalun Li, Yan Song, Jing Wang, Xiaoli Feng, Yi Fang

CANCER LETTERS (2019)

Article Oncology

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer

Andrew McGuire, Maire-Caitlin Casey, Ronan M. Waldron, Helen Heneghan, Olga Kalinina, Emma Holian, Ailbhe McDermott, Aoife J. Lowery, John Newell, Roisin M. Dwyer, Nicola Miller, Maccon Keane, James A. L. Brown, Michael J. Kerin

CANCERS (2020)

Article Oncology

Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data

Xiangyi Kong, Yihang Qi, Junjie Huang, Yang Zhao, Yongle Zhan, Xuzhen Qin, Zhihong Qi, Adejare (Jay) Atanda, Lei Zhang, Jing Wang, Yi Fang, Peng Jia, Asieh Golozar, Lin Zhang, Yu Jiang

Summary: The overall prevalence of cancer among COVID-19 patients is low, but higher in Europe. Cancer prevalence is higher in patients aged over 60. The severity and mortality rates in COVID-19 patients with cancer are relatively high, especially in Europe.

CANCER LETTERS (2021)

Article Cell Biology

A Novel Mechanism of Ataxia Telangiectasia Mutated Mediated Regulation of Chromatin Remodeling in Hypoxic Conditions

Maria Likhatcheva, Roben G. Gieling, James A. L. Brown, Constantinos Demonacos, Kaye J. Williams

Summary: Genotoxic stress can activate the ATM kinase, with potential involvement of Suv39H1 and Tip60 in ATM activation under hypoxic conditions.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Cell Biology

Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer

Li Chen, Xiangyi Kong, Yi Fang, Shishir Paunikar, Xiangyu Wang, James A. L. Brown, Emer Bourke, Xingrui Li, Jing Wang

Summary: Discoidin domain receptor tyrosine kinases (DDRs) are a type of receptor tyrosine kinases associated with various diseases, widely expressed in different cell types and involved in signaling pathways, closely related to the development and progression of solid tumors.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Editorial Material Biochemistry & Molecular Biology

Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways

Amila Suraweera, James A. L. Brown, Yi Chieh Lim, Martin F. Lavin

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Editorial Material Cell Biology

Editorial: Mechanisms guarding the genome

James A. L. Brown, E. Bourke, W. W. Hancock, D. J. Richard

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Multidisciplinary Sciences

Profiling leadership: Attitudes, knowledge and training in the biological sciences

James A. L. Brown

Summary: This study shows that academic staff in the biological sciences are eager to receive formal leadership skills training, but there is no clear evidence that they have received such training. The study also found that they are more interested in systemic leadership, which is lacking in the workplace. Therefore, specific leadership skills training should be incorporated into professional development programs in the field of biological sciences.

PLOS ONE (2023)

Article Oncology

Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort

Amirhossein Jalali, David Miresse, Matthew R. Fahey, Niamh Ni Mhaonaigh, Andrew McGuire, Emer Bourke, Michael J. Kerin, James A. L. Brown

Summary: The study demonstrates the prognostic value of systemic blood-based immunocyte ratios in neoadjuvant chemotherapy-treated breast cancer patients, with significant associations found between different immunocyte ratios and subtype-specific outcomes.

CURRENT ONCOLOGY (2022)

Article Public, Environmental & Occupational Health

Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1-2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study

Xiangyu Wang, Yinqi Gao, Xue Yang, Xiangyi Kong, Zixing Wang, Yi Fang, Jing Wang

IRANIAN JOURNAL OF PUBLIC HEALTH (2020)

Review Oncology

Artificial intelligence: a key to relieve China's insufficient and unequally-distributed medical resources

Xiangyi Kong, Bolun Ai, Yiming Kong, Lijuan Su, Yunzhou Ning, Newton Howard, Shun Gong, Chen Li, Jie Wang, Wan-Ting Lee, Jing Wang, Yanguo Kong, Jingping Wang, Yi Fang

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH (2019)

Article Pharmacology & Pharmacy

Patent spotlight: small-molecule lysine acetyltransferase inhibitors (KATi)

James A. L. Brown

PHARMACEUTICAL PATENT ANALYST (2020)

No Data Available